Chemo-embolization for unresectable hepatocellular carcinoma with different sizes of embolization particles
- PMID: 18046645
- DOI: 10.1007/s10620-007-9995-x
Chemo-embolization for unresectable hepatocellular carcinoma with different sizes of embolization particles
Abstract
The purpose of this study was to evaluate the size responses and vascular responses to three different sizes of Embosphere (EMBS) embolization particles used for chemo-embolization in patients with unresectable hepatocellular carcinoma (HCC). Forty-seven patients with biopsy proven HCC treated with TACE using EMBS (Biosphere Medical, Rockland, MA, USA) were included in this study. EMBS are non-resorbable tris-acryl gelatin defined-size microspheres. Sixteen patients were treated with 40-120 micron (40-microm), 13 patients with 100-300 (100-microm), and 18 patients with 300-500 (300-microm) EMBS particles. We measured the two-dimensional area and vascularity of the tumor index lesion on initial and subsequent CTs after treatment. Lesions were classified into four grades based on the degree of vascularity measured in 25% increments. Size of tumor after one treatment decreased by an average (avg) of 18% for 40-120-microm particles, 38% for 100-300-microm particles, and 17% for 300-500-microm particles. After three treatments, size decreased by an avg of 46% for 40-120-microm particles, 76% for 100-300-microm particles, and 46% for 300-500-microm particles. Vascularity decrease was also measured after the first and third treatments, and defined as a decrease of one or more grades in tumor vascularity. Results were as follows (% of patients with decrease). For 40-120-microm particles: 1 and 3 treatments, 53% and 88% of patients. For 100-300-microm particles: 1 and 3 treatments, 60% and 88% of patients. For 300-500-microm particles: 1 and 3 treatments, 50% and 57% of patients. It was concluded the 100-300-microm EMBS particles produce slightly higher responses.
Similar articles
-
Bland embolization in patients with unresectable hepatocellular carcinoma using precise, tightly size-calibrated, anti-inflammatory microparticles: first clinical experience and one-year follow-up.Cardiovasc Intervent Radiol. 2010 Jun;33(3):552-9. doi: 10.1007/s00270-009-9752-y. Epub 2009 Dec 3. Cardiovasc Intervent Radiol. 2010. PMID: 19957182
-
Chemoembolization of Neuroendocrine Liver Metastases Using Streptozocin and Tris-acryl Microspheres: Embozar (EMBOsphere + ZAnosaR) Study.Cardiovasc Intervent Radiol. 2017 Mar;40(3):394-400. doi: 10.1007/s00270-016-1535-7. Epub 2016 Dec 29. Cardiovasc Intervent Radiol. 2017. PMID: 28035432
-
Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.AJR Am J Roentgenol. 2009 Dec;193(6):1665-71. doi: 10.2214/AJR.08.1806. AJR Am J Roentgenol. 2009. PMID: 19933662
-
Liver chemoembolization of hepatocellular carcinoma using TANDEM® microspheres.Future Oncol. 2018 Nov;14(26):2761-2772. doi: 10.2217/fon-2018-0237. Epub 2018 Jun 28. Future Oncol. 2018. PMID: 29953255 Review.
-
Transarterial chemoembolization in a patient with recurrent hepatocellular carcinoma and portal vein thrombosis: a case report and review of the literature.Am J Clin Oncol. 2005 Dec;28(6):638-9. doi: 10.1097/01.coc.0000158488.36371.50. Am J Clin Oncol. 2005. PMID: 16317281 Review.
Cited by
-
Clinical Study on the Treatment of Benign Prostatic Hyperplasia by Embolization of Prostate Artery Based on Embosphere Microspheres and Gelatin Sponge Granules.J Healthc Eng. 2022 Jan 25;2022:1424021. doi: 10.1155/2022/1424021. eCollection 2022. J Healthc Eng. 2022. PMID: 35126897 Free PMC article.
-
Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.Cancer. 2010 Mar 1;116(5):1305-14. doi: 10.1002/cncr.24884. Cancer. 2010. PMID: 20066715 Free PMC article.
-
Current trends and perspectives in interventional radiology for gastrointestinal cancers.World J Radiol. 2021 Oct 28;13(10):314-326. doi: 10.4329/wjr.v13.i10.314. World J Radiol. 2021. PMID: 34786187 Free PMC article.
-
Interventional radiology and the care of the oncology patient.Radiol Res Pract. 2011;2011:160867. doi: 10.1155/2011/160867. Epub 2011 Mar 29. Radiol Res Pract. 2011. PMID: 22091374 Free PMC article.
-
Current status of embolic agents for liver tumor embolization.Int J Clin Oncol. 2012 Aug;17(4):306-15. doi: 10.1007/s10147-012-0445-1. Epub 2012 Jul 18. Int J Clin Oncol. 2012. PMID: 22806426 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous